# Registry First Wave Pilot A Creatinine Source Transition S2 Review Packet 2026-08-24 v0.1

Status: Draft / Founder Review Pending / Creatinine Source-Verified Transition Not Yet Committed

Prepared date: 2026-08-24

## 1. Purpose

This packet presents the locally executed Creatinine Source Transition S2 for final Founder review. It records the exact approved lineage, seven-source reverification, nine-leaf record diff, validation evidence, and continuing non-authorizations. It does not approve, commit, push, human-review, activate, publish, or runtime-enable the record.

## 2. Repository Baseline

- Repository: `/Users/lanyaodong/Documents/congtie-api`
- Branch: `main`
- HEAD: `a99b5312403d29c20383427cf746d0f26274987c`
- origin/main: `a99b5312403d29c20383427cf746d0f26274987c`
- Initial staging: empty
- Execution date: `2026-08-24`

The branch, local HEAD, remote anchor, staging state, date, and all required protected SHAs passed before local execution.

## 3. Exact C33 Lineage

| Artifact | Path | SHA-256 |
| --- | --- | --- |
| Source-Verified Transition Plan | `agent/knowledge_seed_v0/registry_first_wave_pilot_a_source_verified_transition_plan_2026_08_24.v0.1.md` | `dd627b31e887553b85179da78f47a504ef7da5df8113b6154bbcee4ec5f70121` |
| Transition Plan Founder Approval | `agent/knowledge_seed_v0/registry_first_wave_pilot_a_source_verified_transition_plan_founder_approval_2026_08_24.v0.1.md` | `d3d90474ef17233bd8dbe0b7cc39409db061c1b0ee30a45a0e088fe9dac2f0c8` |

C33 and its approval establish S2 as a separate lifecycle gate after the exact unit-conversion source prerequisite is satisfied.

## 4. Exact C36 and C37 Lineage

| Artifact | Path | SHA-256 |
| --- | --- | --- |
| C36 Creatinine Source-Addition Review Packet | `agent/knowledge_seed_v0/registry_first_wave_pilot_a_creatinine_s2_source_addition_review_packet_2026_08_24.v0.1.md` | `671654fc947a7c39bd915f44d12a049eda6697bfe098fc18b904afe39a987c44` |
| C37 Source-Addition Founder Approval | `agent/knowledge_seed_v0/registry_first_wave_pilot_a_creatinine_s2_source_addition_founder_approval_2026_08_24.v0.1.md` | `d34921843a9f8a1efcc65e941d3707ab838fdb930b471365bf8062d80755629b` |

The committed C37 record contains seven unique sources, including the exact NIDDK conversion authority, and the enzymatic Profile resolves the approved four-key source set.

## 5. S2 Execution Authorization

Path:

`agent/knowledge_seed_v0/registry_first_wave_pilot_a_creatinine_source_transition_s2_execution_authorization_2026_08_24.v0.1.md`

SHA-256:

`309abe87dca5913d8454b80bbeee192e83a662145a18614d889486b4d4b07369`

Status:

`Founder Authorized for Local Creatinine Source Transition S2 Execution / Final Version-Control Approval Pending`

The authorization permits only the exact local S2 lifecycle/source-check metadata transition and requires a separate exact-SHA Founder approval before commit or push.

## 6. Creatinine SHA Before

Path:

`agent/biomarker_measurement_registry/records/BM-000023.creatinine.json`

Pre-S2 SHA-256:

`c8fd286a46334e2f9a4856503de37ff5d8f5dcdfc7128f8e5a7308ae75ae0fa6`

The pre-S2 working-tree bytes matched the HEAD version.

## 7. Creatinine SHA After

Local post-S2 SHA-256:

`396661e7b187beaab9717b042a991dc185a62857f3f1b01a3aa1b4d9d3b51e01`

The validated temporary file and repository file are byte-identical.

## 8. Seven Sources Reopened

All seven current SourceReference targets were reopened on `2026-08-24`. Official terminology, government, standards, publisher, and public-health pages or documents were inspected directly; search snippets were not used as substitutes for content review.

1. `src-loinc-creat-mass` - LOINC `2160-0`;
2. `src-loinc-creat-molar` - LOINC `14682-9`;
3. `src-nist-creat` - NIST creatinine reference-measurement project;
4. `src-creat-method-2020` - DOI `10.1093/jalm/jfaa053`, PMID `32447368`;
5. `src-wst4045` - official WS/T 404.5-2015 PDF;
6. `src-ucum` - UCUM Specification; and
7. `src-niddk-creatinine-conversion` - NIDDK eGFR Equations for Adults.

## 9. Source Verification Matrix

| Source key | Access result | Recorded role confirmed | Supports still valid | Does not support / scope boundary | Supersession or correction status | Access / legal note | S2 blocker |
| --- | --- | --- | --- | --- | --- | --- | --- |
| `src-loinc-creat-mass` | PASS: official LOINC term page opened; `2160-0` is Active | `other_reviewed_role` | Serum/plasma creatinine mass-concentration terminology and mapping | Method is null; does not establish enzymatic identity, assay equivalence, or kidney-function equivalence | Active; no deprecation shown | Public term page under LOINC licensing terms | no |
| `src-loinc-creat-molar` | PASS: official LOINC term page opened; `14682-9` is Active | `other_reviewed_role` | Serum/plasma creatinine molar-concentration terminology and mapping | Method is null; does not establish enzymatic identity, assay equivalence, or kidney-function equivalence | Active; no deprecation shown | Public term page under LOINC licensing terms | no |
| `src-nist-creat` | PASS: official NIST project page opened; project status Ongoing; page updated 2025-03-26 | `measurement_method` | Reference measurement, isotope-dilution mass spectrometry, reference materials, and traceability context | Does not establish equivalence of every commercial assay or diagnose kidney disease | The page documents that SRM 967 was superseded by SRM 967a; the current project/source scope remains valid | Public U.S. government page | no |
| `src-creat-method-2020` | PASS: official publisher full article and PubMed metadata reviewed; DOI/PMID match | `validation_evidence` | Jaffe-versus-enzymatic comparability, observed bias, glucose/hemolysis interference, and continuity limitations | Single-center/platform evidence does not establish universal continuity, every-assay equivalence, or diagnosis | No retraction or materially affecting correction identified on reviewed official records | Publisher labels article free; review stayed within legally accessible content | no |
| `src-wst4045` | PASS: official NHC landing page and complete 8-page PDF reviewed | `reference_interval_source` | China adult serum urea/creatinine interval and applicability context; ID-MS traceability and enzymatic/Jaffe method context | Does not establish a universal interval, plasma applicability without assessment, assay equivalence, or kidney-function equivalence | WS/T 404.5-2015 identity confirmed; no withdrawal or replacement notice identified on the reviewed official source | Public official standard PDF; no restricted content persisted in the repository | no |
| `src-ucum` | PASS: official UCUM Specification opened; version 2.2 dated 2024-06-17 | `other_reviewed_role` | Machine-readable unit syntax and semantics | Does not establish method equivalence, clinical interpretation, or personal targets | Current reviewed specification; no materially affecting supersession shown | Public specification under stated copyright/license terms | no |
| `src-niddk-creatinine-conversion` | PASS: official NIDDK page opened; last reviewed May 2025 | `other_reviewed_role` | Standardized serum creatinine context and the rule to divide umol/L by 88.4 to obtain mg/dL, algebraically equivalent to multiplying mg/dL by 88.4 | Does not establish assay/platform equivalence, reference intervals, diagnosis, personal targets, or action | No withdrawal or materially affecting supersession shown | Public U.S. government health-information page | no |

All recorded source roles, `supports`, and `does_not_support` boundaries remain appropriate. No SourceReference content, key, role, URL, identifier, note, or verification status changed.

## 10. Exact RegistryConcept Lifecycle Change

~~~text
lifecycle_status:
proposed -> source_verified
~~~

This status means the canonical Creatinine definition and at least one embedded Profile meet the governed source-verification conditions. It does not mean human review, active status, clinical utility, publication, runtime, retrieval, diagnosis, treatment, or action.

## 11. Exact Profile-Status Change

Only `creatinine.serum_or_plasma.enzymatic` changed:

~~~text
profile_status:
proposed -> source_verified
~~~

No Profile was added, removed, widened, narrowed, or otherwise revised.

## 12. Six Access-Date Changes

The following six sources were reopened and changed from `2026-08-22` to `2026-08-24`:

- `src-loinc-creat-mass`;
- `src-loinc-creat-molar`;
- `src-nist-creat`;
- `src-creat-method-2020`;
- `src-wst4045`; and
- `src-ucum`.

Only `access_date` changed in these six SourceReference objects.

## 13. NIDDK Date Unchanged

`src-niddk-creatinine-conversion.access_date` was already `2026-08-24` and remains byte-identical. Its full SourceReference object is unchanged.

## 14. Governance Dates Unchanged

The C37 content revision had already set:

~~~text
governance_metadata.last_modified_date = 2026-08-24
governance_metadata.last_source_check_date = 2026-08-24
~~~

Both values remain unchanged. `created_date`, `reviewed_by`, and `reviewed_date` also remain unchanged.

## 15. Exact Status-Note Change

The prior proposed-record note was replaced with the exact C33-approved text:

> Source verification completed for the canonical Creatinine definition and creatinine.serum_or_plasma.enzymatic Profile after exact unit-conversion authority was added. RegistryConcept and Profile are source_verified only; no assay equivalence, human review, active status, publication, runtime, retrieval, clinical claim, threshold or action authorization.

No other governance note changed.

## 16. Exact Nine-Leaf Diff

~~~text
Changed existing scalar leaves = 9
Authorized leaves = 9
Unauthorized leaves = 0

Added keys = 0
Removed keys = 0
Added source objects = 0
Removed source objects = 0
Added Profile keys = 0
Removed Profile keys = 0
Array reordering = 0
~~~

The nine leaves are the RegistryConcept lifecycle, enzymatic Profile status, six reopened-source access dates, and governance status note.

## 17. JSON Result

~~~text
Temporary record JSON syntax: PASS
Repository record JSON syntax: PASS
Encoding: UTF-8
Indentation: 2 spaces
Final newline: present
Temporary/repository byte parity: PASS
~~~

## 18. Schema Result

The temporary and repository records both pass the final Draft 2020-12 Registry Schema with `jsonschema[format]==4.25.1` under Python `3.9.6`.

~~~text
Schema validation = PASS
Schema errors = 0
~~~

## 19. Permanent Validator Result

The permanent authoring Validator returned:

~~~text
VALID: Registry concept record
exit = 0
warnings = 0
errors = 0
~~~

The same result was obtained before and after copying the validated temporary bytes into the repository record.

## 20. Candidate Ledger Lineage Result

Candidate Ledger resolution passed for `creatinine`:

~~~text
candidate_key = creatinine
namespace = BM
first_wave_proposed = true
Candidate Ledger SHA unchanged = PASS
~~~

The Candidate Ledger remains unchanged and is not a lifecycle authority for the canonical record.

## 21. Cross-Registry Result

The Cross-Registry gate passed `25/25` checks:

~~~text
Registry records = 4
Height concept/Profile = source_verified
Body Weight concept/Profile = source_verified
Creatinine concept/Profile = source_verified
Heart Rate concept and both Profiles = proposed
Creatinine sources = 7 unique keys
Claims, thresholds, reference contexts, system relations, and device mappings added = 0
Human-reviewed lifecycle records = 0
Active/runtime/retrieval/published records = 0
Protected SHAs unchanged = PASS
~~~

## 22. Version Decision

`version` remains `v0.1`.

S2 changes only lifecycle/source-check metadata after the already-approved conversion-source addition. It does not revise the Creatinine construct, Profile boundary, specimen, method, units, formula, mappings, comparability, limitations, permissions, or source content. Git will preserve the transition history after a separately authorized commit.

## 23. Human-Review Boundary

This packet is for Founder review of the exact local S2 bytes. The record fields remain:

~~~text
reviewed_by = []
reviewed_date = null
~~~

`source_verified` is not `human_reviewed`. Founder approval of a later commit does not silently promote the Registry lifecycle to `human_reviewed` or `active`.

## 24. Registry State

After local S2 execution:

~~~text
Effective numeric-ID reservations = 4
Registry records = 4

Source-verified concepts = 3
Source-verified Profiles = 3

Height RegistryConcept/Profile = source_verified
Body Weight RegistryConcept/Profile = source_verified
Creatinine RegistryConcept/Profile = source_verified

Heart Rate RegistryConcept = proposed
heart_rate.spot_clinical = proposed
heart_rate.wearable_ppg_time_series_estimate = proposed

Human-reviewed lifecycle records = 0
Active records = 0
Runtime-enabled records = 0
Retrieval-enabled records = 0
Published records = 0
User observations = 0
~~~

The Creatinine lifecycle transition exists only in the uncommitted working tree at this gate.

## 25. Explicit Non-Authorizations

This local execution and review packet do not authorize:

- commit or push;
- Heart Rate S3;
- any transition to `human_reviewed` or `active`;
- source, Profile, method, specimen, unit, formula, mapping, comparability, limitation, permission, or ID changes;
- claims, thresholds, ReferenceContexts, system relations, lifecycle relations, or device mappings;
- runtime, retrieval, publication, database, API, loader, index, Observation processing, Service Panel, or user-health storage;
- diagnosis, treatment, personal targets, or action authorization.

## 26. Founder Decision Sheet

| # | Decision | Founder Decision |
| ---: | --- | --- |
| 1 | Approve final Creatinine RegistryConcept and enzymatic Profile at `source_verified` | Pending |
| 2 | Approve exact nine-leaf S2 diff and seven-source reverification | Pending |
| 3 | Authorize a later controlled commit/push of the S2 authorization, exact revised record, this review packet and an exact-SHA S2 Founder approval closeout | Pending |

~~~text
Founder approvals = 0
Founder pending decisions = 3
Accidental approvals = 0
~~~

## 27. Recommended Next Gate

`Step5-C39: Final Founder Approval + Controlled Commit/Push - Creatinine Source Transition S2`

The next gate should bind approval to the exact S2 authorization SHA, revised Creatinine SHA, this Review Packet SHA, and the verified nine-leaf diff. It must not execute Heart Rate S3 or authorize runtime, retrieval, publication, human-reviewed, or active status.
